对于核酸疫苗的分子辅助剂的进展
Casey E Hojecki1, Nicholas J Tursi1,2, Cory Livingston1
1The Vaccine & Immunotherapy Center, The Wistar Institute, Philadelphia, PA, United States.
Frontiers in immunology
|October 15, 2025
概括
现代辅助剂通过塑造免疫反应来增强核酸疫苗. 在mRNA-LNP和DNA疫苗的进步,包括内在的辅助性质,是提高免疫性和疫苗疗效的关键.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 自20世纪90年代以来,核酸疫苗技术已经取得了重大进展.
- 随着COVID-19的流行,mRNA-LNP和DNA疫苗的研发和批准加速了针对SARS-CoV-2的发展和批准.
- 早期的DNA疫苗显示出有限的免疫性,强调了对辅助分子的需求.
研究的目的:
- 审查核酸疫苗的分子辅助物格局.
- 总结最近关于增强核酸疫苗免疫性辅助剂的发现.
- 讨论像脂质纳米颗粒 (LNP) 这样的输送系统的内在辅助活性.
主要方法:
- 关于分子辅助剂和核酸疫苗技术的文献综述.
- 对研究细胞因子,化学因子和酶作为分子辅助剂的研究进行分析.
- 检查输送系统 (例如,LNP) 在疫苗免疫性中的作用.
主要成果:
- 分子辅助剂,包括编码的细胞因子和化学因子,增强核酸抗原诱导的免疫力.
- 由于其输送方式,mRNA-LNP和DNA-LNP疫苗表现出内在辅助活性.
- 辅助剂策略对于优化核酸疫苗引起的定量和定性免疫反应至关重要.
结论:
- 分子辅助剂对于提高核酸疫苗的疗效至关重要.
- 像LNP这样的输送系统对核酸疫苗的免疫性有着显著的贡献.
- 对辅助技术的持续研究对于推动核酸疫苗开发至关重要.
更多相关视频
13:36Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
10.7K
07:32Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
Published on: September 1, 2023
2.3K
相关概念视频
Microorganisms in Medicine and Therapeutics
960
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
960
Vaccinations
51.2K
Overview
51.2K
Antigens Involved in Adaptive Immunity
1.3K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.3K
